AdaptHealth Capital Markets Day to Highlight Progress Executing Strategy to Transform Healthcare by Keeping Patients Healthy at Home

Rhea-AI Summary

AdaptHealth Corp. (NASDAQ: AHCO) announced new long-term financial goals during its 2022 Capital Markets Day. CEO Steve Griggs highlighted the company's progress in establishing a scalable foundation for profitable growth and shareholder value. The company aims to lead the shift to connected in-home healthcare, emphasizing its commitment to cost-effective patient care. AdaptHealth serves approx. 3.9 million patients annually, leveraging operational excellence and strategic acquisitions. The firm is focused on enhancing its chronic disease management programs and expanding its connected care offerings.

Positive

• Introduced long-term financial goals aimed at profitable growth.
• Serves approximately 3.9 million patients annually, indicating strong market presence.
• Focus on enhancing chronic disease management programs and connected care offerings.

Negative

• None.

Company Introduces New Long-Term Financial Goals

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)-- AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will host and webcast its 2022 Capital Markets Day beginning at 9:00 a.m. ET today.

During the event, Chief Executive Officer Steve Griggs, President Josh Parnes, Chief Financial Officer Jason Clemens, and other members of AdaptHealth’s senior leadership team will provide in-depth reviews of the Company’s business model and competitive differentiation, review its progress in establishing a scalable foundation for profitable growth and shareholder value going forward, and introduce long-term financial goals.

Management will also discuss the critical role AdaptHealth plays in the healthcare continuum today, and will demonstrate how the Company is positioned to continue to lead the shift to connected in-home healthcare and evolving reimbursement models in the future.

“We are proud to showcase the tremendous progress we have made in building an organization that delivers essential, cost-effective care and helps enable our more than 3.9 million patients to live their best lives, healthy at home,” said Griggs. “Through acquisitions, organic investments, and operational excellence, we have repositioned AdaptHealth with valuable scale, operating leverage, and value creation potential for patients, payors, providers, and shareholders. Today, we are well-positioned with a tech-enabled patient first care model, a broad portfolio of market-leading sleep, respiratory and diabetes solutions, world-class compliance, and a growing network of touchpoints into the patient’s home -- including 36,000 daily deliveries, 650 patient advocate sales reps, and over 1,000 AdaptHealth healthcare professionals.”

“We are excited about AdaptHealth’s future opportunities as we continue delivering on our vision to be the leading provider of equipment and services that empower healthcare at home. By leveraging our established foundation and executing on our ongoing growth and efficiency priorities, we are positioning AdaptHealth to drive toward our new three-year financial goals. Simultaneously, we are unlocking future opportunities as we pioneer the shift to connected care at home through our AdaptHealth 2.0 model where we are focused on embracing and expanding our connected care offerings, growing our chronic disease management programs, and tightening our connection to the payor community.”

Investor Day Webcast

The webcast of the presentation, as well as copies of the accompanying slides, will be available in the Events & Presentations section of AdaptHealth’s investor relations website. A webcast replay also will be available on the website following the event.

About AdaptHealth Corp.

AdaptHealth is a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company provides a full suite of medical products and solutions designed to help patients manage chronic conditions in the home, adapt to challenges in their activities of daily living, and thrive. Product and service offerings include (i) sleep therapy equipment, supplies, and related services (including CPAP and bi PAP services) to individuals suffering from obstructive sleep apnea, (ii) medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors and insulin pumps), (iii) HME to patients discharged from acute care and other facilities, (iv) oxygen and related chronic therapy services in the home, and (v) other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. The Company is proud to partner with an extensive and highly diversified network of referral sources, including acute care hospitals, sleep labs, pulmonologists, skilled nursing facilities, and clinics. AdaptHealth services beneficiaries of Medicare, Medicaid, and commercial insurance payors, reaching approximately 3.9 million patients annually in all 50 states through its network of over 750 locations in 47 states.

Forward-Looking Statements

This press release includes certain statements that are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook,” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding projections, estimates and forecasts of revenue and other financial and performance metrics and projections of market opportunity and expectations and the Company’s acquisition pipeline. These statements are based on various assumptions and on the current expectations of AdaptHealth management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on, by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of the Company.

These forward-looking statements are subject to a number of risks and uncertainties, including the outcome of judicial and administrative proceedings to which the Company may become a party or governmental investigations to which the Company may become subject that could interrupt or limit the Company’s operations, result in adverse judgments, settlements or fines and create negative publicity; changes in the Company’s customers’ preferences, prospects and the competitive conditions prevailing in the healthcare sector; and the impact of the coronavirus (COVID-19) pandemic and the Company’s response to it. A further description of such risks and uncertainties can be found in the Company’s filings with the Securities and Exchange Commission. If the risks materialize or assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that the Company presently knows or that the Company currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect the Company’s expectations, plans or forecasts of future events and views as of the date of this press release. The Company anticipates that subsequent events and developments will cause the Company’s assessments to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company’s assessments as of any date subsequent to the date of this press release. Accordingly, undue reliance should not be placed upon the forward-looking statements.

Use of Non-GAAP Financial Information and Financial Guidance

This release contains non-GAAP financial guidance, which is adjusted to exclude certain costs, expenses, gains and losses and other specified items that are evaluated on an individual basis. These non-GAAP items are adjusted after considering their quantitative and qualitative aspects and typically have one or more of the following characteristics, such as being highly variable, difficult to project, unusual in nature, significant to the results of a particular period or not indicative of future operating results. Similar charges or gains were recognized in prior periods and will likely reoccur in future periods.

The Company uses EBITDA and Adjusted EBITDA, which are financial measures that are not prepared in accordance with generally accepted accounting principles in the United States, or U.S. GAAP, to analyze its financial results and believes that they are useful to investors, as a supplement to U.S. GAAP measures.

The Company believes Adjusted EBITDA is useful to investors in evaluating the Company’s financial performance. The Company uses this metric as the profitability measure in its incentive compensation plans that have a profitability component and to evaluate acquisition opportunities, where it is most often used for purposes of contingent consideration arrangements.

EBITDA and Adjusted EBITDA should not be considered as measures of financial performance under U.S. GAAP, and the items excluded from EBITDA and Adjusted EBITDA are significant components in understanding and assessing financial performance. Accordingly, these key business metrics have limitations as an analytical tool. They should not be considered as an alternative to net income or any other performance measures derived in accordance with U.S. GAAP or as an alternative to cash flows from operating activities as a measure of the Company’s liquidity.

There is no reliable or reasonably estimable comparable GAAP measure for the Company’s non-GAAP financial guidance because the Company is not able to reliably predict the impact of certain items, including equity-based compensation expense, transaction costs, changes in fair value of the warrant liability, and other non-recurring items of expense or income in full year 2022. As a result, reconciliation of these non-GAAP measures to the most directly comparable GAAP measure is not available without unreasonable effort. In addition, the Company believes such a reconciliation would imply a degree of precision and certainty that could be confusing to investors. The variability of the specified items may have a significant and unpredictable impact on the Company’s future GAAP results.

In addition, the Company’s non-GAAP financial guidance in this release excludes the impact of any potential additional future strategic acquisitions and any specified items that have not yet been identified and quantified. The guidance also excludes macro-economic effects due to the COVID-19 pandemic that are not yet quantifiable. The financial guidance is subject to risks and uncertainties applicable to all forward-looking statements as described elsewhere in this press release.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220916005265/en/

AdaptHealth Corp.

Jason Clemens, CFA

Chief Financial Officer

Anton Hie

Vice President, Investor Relations

IR@adapthealth.com

Source: AdaptHealth Corp.

FAQ

What are AdaptHealth's long-term financial goals announced in 2022?

AdaptHealth introduced new long-term financial goals during its 2022 Capital Markets Day aimed at establishing a scalable foundation for profitable growth and shareholder value.

How many patients does AdaptHealth serve?

AdaptHealth serves approximately 3.9 million patients annually across the United States.

What focus areas did AdaptHealth highlight during its Capital Markets Day?

AdaptHealth emphasized enhancing chronic disease management programs and expanding connected care offerings.

What is the significance of the new goals for AdaptHealth's investors?

The new financial goals are intended to position AdaptHealth for ongoing profitable growth and increased shareholder value.